20314 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
#902NKantagonists
#903IAP BIR domain binding compounds
#904Phenylpyrrole derivative
#905Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
#906Tetrahydrobenzothiophene compound
#907COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#908Gambogenic acid derivatives, preparation method and application thereof
#909Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
#910SMALL MOLECULE SCREEN FOR INHIBITORS OF NFAT: AP-1: DNA INTERACTIONS
#911MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#912Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
#913Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
#914Treatment for diabetes in patients inappropriate for metformin therapy
#915Combination therapy for glaucoma
#916Pharmaceutical compositions of conjugates formed from polymer derivatives having particular atom arrangements
#917Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
#918Indanyloxydihydrobenzofuranylacetic acids
#919Androgen receptor modulator and uses thereof
#920Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#921POLYPHENOL ANALOGS TO TREAT ISCHEMIA
#922NEUROPROTECTIVE POLYPHENOL ANALOGS
#923Methods of treating soft tissue defects
#924Compositions for killing or preventing the growth of microbes
#925Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kinase and method for identifying said molecules
#926Methods of regulating glucose metabolism, and reagents related thereto
#927REDUCTION OF BIOFILMS ON MEDICAL DEVICES
#928SOLID COMPOSITIONS
#929COMPOSITIONS AND IMPROVED SOFT TISSUE REPLACEMENT METHODS
#930INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS
#931Biaryl derivatives as nAChR modulators
#932ANTI-VIRAL COMPOUNDS
#933PREVENTIVES/REMEDIES FOR STRESS URINARY INCONTINENCE AND METHOD OF SCREENING THE SAME
#934Substituted benzoazepines as toll-like receptor modulators
#935SKIN WOUND HEALING AND SCAR REDUCTION WITH PROSTAGLANDIN EP4 AGONIST COMBINATIONS
#936Methods of Treating Retroviral Infections in Felines
#937Ryanodine receptor inhibitors for treatment of T-cell mediated disorders
#938Esters of N-acylated derivatives of amino acids and isosorbide, method for preparing same, and use thereof in cosmetics and as drug
#9392-methylthiopyrrolidines and their use for modulating bacterial quorum sensing
#940Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
#941Cyclic peptides with an anti-neoplasic and anti-angiogenic activity
#942SYNERGISTIC PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
#943Methods to treat pancreatic inflammation and associated lung injury through regulation of pancreatic interleukin-22 expression
#944Therapeutic Methods For Type I Diabetes
#945Estrogen receptor modulators and uses thereof
#946Methods for treating HCV
#947Methods for treating HCV
#948SSH-2 (slingshot-2) inhibitors and methods for making and using them
#949METHODS OF LOWERING PROPROTEIN CONVERSATE SUBTILISIN/KEXIN TYPE 9 (PCSK9)
#950NOVEL SUBSTITUTED TETRAHYDRONAPHTHALENES, PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF AS MEDICAMENTS
#951Methods for Treating HCV
#952Methods and Compositions for the Treatment of Estrogen-Dependent Hyperproliferative Uterine Disorders
#953Identification of compounds that disperse TDP-43 inclusions
#954BRADYKININ B1 ANTAGONISTS
#955Therapy for complications of diabetes
#956Methods of treating muscular dystrophy
#957Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
#958Compounds and their use
#959METHODS AND COMPOSITIONS FOR TREATING BIOFILMS
#960Lipophilic curcumin analogs and methods of inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia
#961TRANSGLUTAMINASE-2 INHIBITORS AND USES THEREOF
#962Phenoxy-pyrrolidine derivative and its use and compositions
#963Pharmaceutical foam
#964Methods for Treating HCV
#965Gamma secretase inhibitors
#966Indole derivative, and pharmacologically acceptable salt thereof
#967Chromene derivatives
#968Methods and compositions for modulating P300/CBP activity
#969SILICONE-BASED OPHTHALMIC FORMULATIONS
#970INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASES
#971MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION
#972Heteroarylcarboxylic acid ester derivative
#973Anti-cancer agents synthesized based on miliusane compounds
#974Inhibitors of viruses
#975PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR
#9761-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
#977Compounds useful for the treatment of metabolic and inflammatory diseases
#978Multikinase inhibitors for use in the treatment of cancer
#979Pyrrolidinones as MetAP-2 inhibitors
#980Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue
#981Fused ring compound for use as mineralocorticoid receptor antagonist
#982Treatment of addiction and impulse-control disorders using PDE7 inhibitors
#983Methods of treating cancer comprising targeting NQO1
#984Indanyloxydihydrobenzofuranylacetic acids
#985Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#986Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia
#987OPHTHALMIC COMPOSITION
#988PHARMACEUTICAL COMBINATION OF PACLITAXEL AND A CDK INHIBITOR
#9893-phenoxymethylpyrrolidine compounds
#990Benzodioxane inhibitors of leukotriene production for combination therapy
#991METHOD AND COMPOSITION FOR TREATING ALZHEIMER'S DISEASE AND DEMENTIAS OF VASCULAR ORIGIN
#992Delayed-release formulation for reducing the frequency of urination and method of use thereof
#993Extended-release formulation for reducing the frequency of urination and method of use thereof
#994FtsZ INHIBITORS AS POTENTIATORS OF BETA-LACTAM ANTIBIOTICS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS
#9953-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity
#996Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
#997Extended-release formulation for reducing the frequency of urination and method of use thereof
#998Pyrrolidine derivatives
#999Benzopyran compounds, compositions and uses thereof
#1000Therapy for complications of diabetes
#1001Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria
#1002ANTIMICROBIAL COMPOUNDS
#1003METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF
#1004Proline sulfonamide derivatives as orexin receptor antagonists
#1005Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
#1006Use of histone acetyltransferase inhibitors as novel anti-cancer therapies
#1007Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
#1008IRE-1α inhibitors
#1009Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein
#1010Methods for treating HCV
#1011Methods for treating HCV
#1012Methods for treating HCV
#1013Methods for treating HCV
#1014Cross-media voice mail notification and delivery
#1015EP4 agonist
#1016Antibacterial agents
#1017IAP BIR domain binding compounds
#1018NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#1019Pyrrolidin-3-ylacetic acid derivative
#1020COMPOUNDS, PREPARATION AND USES THEREOF
#1021Combination methods for treatment of disease
#1022Tetrahydrobenzothiophene compound
#1023Sulphone compounds and methods of making and using same
#1024Secondary structure stabilized NMDA receptor modulators and uses thereof
#1025INHIBITORS OF CYCLIN-DEPENDENT KINASES AND THEIR USE
#1026Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
#1027PROMOTION OF WOUND HEALING
#1028mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
#1029Compositions for treating cognitive disorders
#1030TREATMENT OF PROLIFERATIVE DISORDERS
#1031TETRAHYDROBENZOTHIOPHENE COMPOUND
#1032TWO PART FORMULATION SYSTEM FOR OPTHALMIC DELIVERY
#1033KALLIKREIN 7 MODULATORS
#1034NK1 antagonists
#1035SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY
#1036Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
#1037METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS
#10383-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
#1039Extracts from kibdelos porangium as antibacterial agents
#1040MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#1041Coumarin compounds as receptor modulators with therapeutic utility
#10422-acylaminopropoanol-type glucosylceramide synthase inhibitors
#1043COMBINATION CANCER THERAPY WITH HERV INHIBITION
#1044Pyrrolidine substitute flavones for the treatment of inflammatory disorders
#1045Compounds for inhibiting cell proliferation in EGFR-driven cancers
#10463-phenoxymethylpyrrolidine compounds
#1047Treatment of atrial fibrillation
#1048Compounds, formulations, and methods of protein kinase C inhibition
#1049Alkanoylamino benzamide aniline HDAC inhibitor compounds
#1050Synthesis of UDP-Glucose: -acylsphingosine glucosyl transferase inhibitors
#1051Compositions and methods for treating seizure disorders
#1052Compounds for use in treatment of mucositis
#1053Hematopoietic growth factor mimetic small molecule compounds and their uses
#1054Extended-release formulation for reducing the frequency of urination and method of use thereof
#1055COMBINATIONS OF DARIFENACIN AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER
#1056COMBINATIONS OF DARIFENACIN AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER
#1057Oligomer-opioid agonist conjugates
#1058Delayed-release formulation for reducing the frequency of urination and method of use thereof
#1059Heteroarylcarboxylic acid ester derivative
#1060METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCE
#1061Phenoxy-pyrrolidine derivative and its use and compositions
#1062Methods for the treatment and prevention of ocular disorders
#1063Compositions and soft tissue replacement methods
#1064Causal therapy of diseases or conditions associated with CNS or PNS demyelination
#1065METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION
#1066Oligomer-opioid agonist conjugates
#1067Antiviral compounds
#1068Compositions and methods for soft tissue replacement
#1069Solid compositions
#1070AGENT FOR TREATING FIBROMYALGIA
#1071Slow infusion of sulcardine and its salts
#1072EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#1073DELAYED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#1074NON-AQUEOUS SILICONE-BASED OPHTHALMIC FORMULATIONS
#1075IMIDAZOLE DERIVATIVES AND METHODS OF USE THEREOF
#1076Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
#1077SILICONE-BASED OPHTHALMIC FORMULATIONS
#1078Antigen binding proteins
#1079Compositions and soft tissue replacement methods
#1080Compositions and soft tissue replacement methods
#1081Compositions and soft tissue replacement methods
#1082Therapeutic methods for type I diabetes
#1083Alpha adrenergic receptor modulators
#1084TOFA analogs useful in treating dermatological disorders or conditions
#1085Method for treating neovascularization
#1086COMBINATION THERAPY USING A BETA 3 ADRENERGIC RECEPTOR AGONISTS AND AN ANTIMUSCARINIC AGENT
#1087Therapy for enteric infections
#1088METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION
#1089Therapeutic Inhibitor of Vascular Smooth Muscle Cells
#1090Compositions and soft tissue replacement methods
#1091Compositions and soft tissue replacement methods
#1092Oligomer-opioid agonist conjugates
#1093METHODS OF TREATING NEUROPATHIC PAIN
#1094Use of parthenolide derivatives as antileukemic and cytotoxic agents
#1095Method of regulating glucose metabolism, and reagents related thereto
#1096Extended-release formulation for reducing the frequency of urination and method of use thereof
#1097Delayed release formulation for reducing the frequency of urination and method of use thereof
#1098Compounds having analgesic and/or immunostimulant activity
#1099Antiviral compounds
#1100Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
#1101DELAYED RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#1102Estrogen antagonists as treatments for sclerosing disorders
#1103EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#1104ANTIBACTERIAL AGENTS
#1105Anti-Viral Compounds
#1106Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
#1107COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#1108PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES
#1109METHOD OF TREATING CONDITIONS ASSOCIATED WITH OVERACTIVE BLADDER
#1110Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
#1111Inhibitors of hepatitis C virus replication
#1112Novel Therapeutic Treatments Using Centhaquin
#1113Pharmaceutical foam
#1114Method and composition for treating diabetic ketoacidosis
#1115BACE 2 INHIBITORS
#1116Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
#1117COMPOSITIONS AND METHODS FOR TREATING CORNEAL HAZE
#1118COUMARIN COMPOUNDS AND THEIR USE FOR TREATING VIRAL INFECTION
#1119Compositions and soft tissue replacement methods
#1120PROCESS FOR (3R, 5R)-7-[2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-4- [(4-HYDROXY METHYL PHENYL AMINO) CARBONYL]-PYRROL-1-YL]-3, 5-DIHYDROXY-HEPTANOIC ACID HEMI CALCIUM SALT
#1121Inhibiting serum response factor (SRF) to improve glycemic control
#1122Method Of Treating Diabetes Mellitus
#1123INTRANASAL DESMOPRESSIN ADMINISTRATION
#1124Pyrrolinone derivative and pharmaceutical composition comprising the same
#1125Methods of Treating an Overweight or Obese Subject
#1126Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#1127EXTENDED RELEASE FORMULATIONS CONTAINING DARIFENACIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#1128NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#1129Quinazolinone, quinolone and related analogs as sirtuin modulators
#1130Therapeutic Inhibitor of Vascular Smooth Muscle Cells
#11313,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies
#1132Bis(thio-hydrazide amide) formulation
#11331-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
#1134Treatment of a stomach or small intestine ulcer with 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid
#1135COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION
#1136SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS
#1137Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue
#1138Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
#1139Treatment for diabetes in patients inappropriate for metformin therapy
#1140Chromenone analogs as sirtuin modulators
#1141Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor
#1142PHARMACEUTICAL COMBINATION
#1143Melanocortin receptor agonists
#1144METHODS OF IMPROVING QUALITY OF SLEEP
#1145Phenyl propionic acids as PPAR delta activators
#1146Methods for diagnosing and treating asthma
#1147Melanocortin receptor agonists
#1148FAST DISSOLVING DRUG DELIVERY SYSTEMS
#1149HYBRID TRIPYRROLE-OCTAARGININE COMPOUNDS AND THEIR USE AS MEDICAMENT IN THE TREATMENT OF CANCER AND MICROBIAL ILLNESSES
#1150Melanocortin receptor agonists
#1151Synthesis of resorcylic acid lactones useful as therapeutic agents
#1152Compositions and methods for treating spasticity
#1153Use of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinence
#1154Compositions and Methods for Treating Female Sexual Dysfunction
#1155ROSAMINE DERIVATIVES AS AGENTS FOR THE TREATMENT OF CANCER
#1156Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial Dysfunction
#1157Bradykinin B1 antagonists
#1158Tetrahydro-pyran derivatives
#11592-acylaminopropoanol-type glucosylceramide synthase inhibitors
#1160Methods for forming polymer-drug conjugates
#1161Inhibitors of viruses
#1162Compositions and methods for the diagnosis and treatment of tumor
#1163Method of regulating glucose metabolism, and reagents related thereto
#1164Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
#1165COMBINED THERAPY AGAINST TUMORS COMPRISING SUBSTITUTED ACRYLOYL DISTAMYCIN DERIVATIVES AND RADIOTHERAPY
#1166Combination Therapy For Glaucoma
#1167Pyrrole antifungal agents
#1168Smoking Cessation Lozenge Containing Tobacco Alkaloid And Silver Salt
#1169Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#1170Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#1171PYRROLIDINE DERIVATIVES
#1172Inhibitors of cyclin dependent kinases and their use
#1173STABLE AQUEOUS COMPOSITIONS OF PROSTGLANDIN AGONIST PRODRUGS AND METHODS FOR USE THEREOF
#1174Substituted benzoazepines as toll-like receptor modulators
#1175NOVEL ESTROGEN RECEPTOR LIGANDS
#1176MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES
#1177Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
#1178Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic Agents
#1179Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
#1180NKantagonists
#1181COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
#11822-substituted-ethynylthiazole derivatives and uses of same
#1183Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling
#1184COMPOSITIONS AND METHODS FOR TREATING DISORDERS OF GASTROINTESTINAL MOTILITY
#1185Compositions and methods for treating seizure disorders
#1186Hepatitis C virus inhibitors
#1187Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
#1188COMPOSITION AND METHODS USED DURING ANTI-HIV TREATMENT
#1189MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS
#1190PROTON PUMP INHIBITORS
#11913-phenoxymethylpyrrolidine compounds
#1192METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
#1193COMPOSITIONS FOR TREATING COGNITIVE DISORDERS
#1194Targeting CDK4 and CDK6 in cancer therapy
#1195Methods of treating pancreatic or liver cancer using hedgehog antagonists
#1196Synthesis of UDP-glucose: -acylsphingosine glucosyltransferase inhibitors
#1197Methods of treating ocular diseases using derivatives of lipoic acid
#1198Modulation of KCNQ potassium channel activity for treatment of psychiatric disorders and the symptoms thereof
#1199COMPOSITION AND METHOD FOR TREATING ACNE
#1200Antiviral compounds